PACIRA BIOSCIENCES, INC. (NASDAQ: PCRX) – Alvarez v. Pacira BioSciences, et al., 2:25-cv-00322, (January 13, 2025, D.N.J.)

A federal securities class action has been filed on behalf of investors that purchased, or otherwise acquired, Pacira BioSciences securities between August 2, 2023 and August 8, 2024, inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ alleged violations of the federal securities laws.

Learn more about this case by clicking Pacira BioSciences complaint.

If you own PCRX stock and have questions about potential legal claims, please email us at [email protected] or complete our Securities Class Action Questionnaire. All submissions are confidential, evaluations of potential legal claims are free, and there is no obligation to take further action.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

ASP ISOTOPES INC. (NASDAQ: ASPI) – Corredor v. ASP Isotopes Inc., et al., 1:24-cv-09253 (Dec. 4, 2024, S.D.N.Y.)

Securities class action filed on behalf of persons and entities that purchased, or otherwise acquired, ASP Isotopes stock securities between October 30, 2024 and November 26, 2024, inclusive (the “Class Period”), pursuing claims against the Defendants under the Securities Exchange Act of 1934 (the “Exchange Act”).

Learn more about this case by clicking ASP Isotopes complaint.

If you own ASPI stock and have questions about potential legal claims, please email us at [email protected] or complete our Securities Class Action Questionnaire. All submissions are confidential, evaluations of potential legal claims are free, and there is no obligation to take further action.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

CAPRI HOLDINGS (NYSE: CPRI) – Hurwitz v. Capri Holdings Limited, et al., 1:24-cv-01410 (Dec. 23, 2024, D. Del.)

Securities class action filed on behalf of investors that purchased or otherwise acquired Capri Holdings stock or sold Capri puts between August 10, 2023 and October 24, 2024, both dates inclusive (the “Class Period”), seeking to pursue remedies under the Securities Exchange Act of 1934 (the “1934 Act”) against Capri, Tapestry, Inc., and certain Capri and Tapestry senior officers and directors.

Learn more about this case by clicking Capri Holdings complaint.

If you own CPRI stock and have questions about potential legal claims, please email us at [email protected] or complete our Securities Class Action Questionnaire. All submissions are confidential, evaluations of potential legal claims are free, and there is no obligation to take further action.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

MICRON TECHNOLOGY (NASDAQ: MU) –Klein v. Micron Technology, et al., 9:25-cv-80040 (Jan. 9, 2025, S.D. Fla.)

Securities class action filed on behalf of investors that purchased or otherwise acquired Micron Technology common stock between September 28, 2023 and December 18, 2024, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ alleged violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

Learn more about this case by clicking Micron Technology complaint.

If you own MU stock and have questions about potential legal claims, please email us at [email protected] or complete our Securities Class Action Questionnaire. All submissions are confidential, evaluations of potential legal claims are free, and there is no obligation to take further action.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

WOLFSPEED (NYSE: WOLF) – Maizner v. Wolfspeed, Inc., No. 6:25-cv-46 (Jan. 8, 2025, N.D.N.Y.) – Securities class action filed on behalf of investors that purchased or otherwise acquired Wolfspeed securities between August 16, 2023 and November 6, 2024, both dates inclusive (the “Class Period”). Learn more about this case by clicking Wolfspeed complaint.

If you own WOLF stock and have questions about potential legal claims, please email us at [email protected] or complete our Securities Class Action Questionnaire. All submissions are confidential, evaluations of potential legal claims are free, and there is no obligation to take further action.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]

TARGET CORPORATION (NYSE: TG) – McCollum v. Cornell, et al., 2:25-cv-00021 (Jan. 9, 2025, M.D. Fla.) – Verified shareholder derivative complaint filed against certain current and former board members and executive officers seeking to remedy alleged breaches of fiduciary duties and violations of federal law. Learn more about this case by clicking Target Corporation complaint.

If you own TG stock and have questions about potential legal claims, please email us at [email protected] or complete our Securities Class Action Questionnaire. All submissions are confidential, evaluations of potential legal claims are free, and there is no obligation to take further action.

PHONE

Tel: 215-792-6676

EMAIL

[email protected]